BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 25009098)

  • 1. Neoadjuvant taxane-based combination chemotherapy in patients with advanced penile cancer.
    Djajadiningrat RS; Bergman AM; van Werkhoven E; Vegt E; Horenblas S
    Clin Genitourin Cancer; 2015 Feb; 13(1):44-9. PubMed ID: 25009098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II study of docetaxel, cisplatin, and fluorouracil in patients with distantly metastatic penile cancer as first-line chemotherapy.
    Zhang S; Zhu Y; Ye D
    Oncotarget; 2015 Oct; 6(31):32212-9. PubMed ID: 26311739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Taxanes in combination with cisplatin and fluorouracil for advanced penile cancer: preliminary results.
    Pizzocaro G; Nicolai N; Milani A
    Eur Urol; 2009 Mar; 55(3):546-51. PubMed ID: 18649992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Factors of Adjuvant Taxane, Cisplatin, and 5-Fluorouracil Chemotherapy for Patients With Penile Squamous Cell Carcinoma After Regional Lymphadenectomy.
    Necchi A; Lo Vullo S; Nicolai N; Raggi D; Giannatempo P; Colecchia M; Catanzaro M; Torelli T; Piva L; Biasoni D; Stagni S; Mariani L; Salvioni R
    Clin Genitourin Cancer; 2016 Dec; 14(6):518-523. PubMed ID: 27050716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant docetaxel, cisplatin and 5-fluorouracil (TPF) in locally advanced squamous cell carcinoma of the head and neck.
    Baghi M; Hambek M; May A; Radeloff A; Gstoettner W; Knecht R
    Anticancer Res; 2006; 26(1B):559-63. PubMed ID: 16739320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Combination of Cisplatin and 5-Fluorouracil With a Taxane in Patients Who Underwent Lymph Node Dissection for Nodal Metastases From Squamous Cell Carcinoma of the Penis: Treatment Outcome and Survival Analyses in Neoadjuvant and Adjuvant Settings.
    Nicolai N; Sangalli LM; Necchi A; Giannatempo P; Paganoni AM; Colecchia M; Piva L; Catanzaro MA; Biasoni D; Stagni S; Torelli T; Raggi D; Faré E; Pizzocaro G; Salvioni R
    Clin Genitourin Cancer; 2016 Aug; 14(4):323-30. PubMed ID: 26341040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant docetaxel, cisplatin and ifosfamide (ITP) combination chemotherapy for treating penile squamous cell carcinoma patients with terminal lymph node metastasis.
    Xu J; Li G; Zhu SM; Cai QL; Wang Z; Yang X; Zhang HT; Niu YJ
    BMC Cancer; 2019 Jun; 19(1):625. PubMed ID: 31238987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II trial of docetaxel, cisplatin and 5FU chemotherapy in locally advanced and metastatic penis cancer (CRUK/09/001).
    Nicholson S; Hall E; Harland SJ; Chester JD; Pickering L; Barber J; Elliott T; Thomson A; Burnett S; Cruickshank C; Carrington B; Waters R; Bahl A
    Br J Cancer; 2013 Nov; 109(10):2554-9. PubMed ID: 24169355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant TPF in locally advanced head and neck cancer can be followed by radiotherapy combined with cisplatin or cetuximab: a study of 157 patients.
    Fayette J; Bonnin N; Ferlay C; Lallemant B; Ramade A; Favrel V; Zrounba P; Chabaud S; Pommier P; Poupart M; Céruse P
    Anticancer Drugs; 2013 Jul; 24(6):623-9. PubMed ID: 23542750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer.
    Vermorken JB; Remenar E; van Herpen C; Gorlia T; Mesia R; Degardin M; Stewart JS; Jelic S; Betka J; Preiss JH; van den Weyngaert D; Awada A; Cupissol D; Kienzer HR; Rey A; Desaunois I; Bernier J; Lefebvre JL;
    N Engl J Med; 2007 Oct; 357(17):1695-704. PubMed ID: 17960012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neoadjuvant and adjuvant chemotherapy with paclitaxel, cisplatin and 5-fluorouracil for advanced penile cancer: a case report].
    Takamoto D; Kasuga J; Yumura Y; Koizumi M; Hanai T; Ishida H; Hattori Y; Teranishi J; Miyoshi Y; Kondo K; Noguchi K
    Hinyokika Kiyo; 2014 Feb; 60(2):95-8. PubMed ID: 24755822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neoadjuvant and adjuvant chemotherapy in patients with advanced penile cancer].
    Heidenreich A; Jakse G
    Urologe A; 2007 Oct; 46(10):1395-6, 1398-9. PubMed ID: 17846739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of docetaxel and cisplatin chemotherapy in 5-fluorouracil/cisplatin pretreated esophageal cancer.
    Shim HJ; Cho SH; Hwang JE; Bae WK; Song SY; Cho SB; Lee WS; Joo YE; Na KJ; Chung IJ
    Am J Clin Oncol; 2010 Dec; 33(6):624-8. PubMed ID: 20142726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up.
    Rapidis AD; Trichas M; Stavrinidis E; Roupakia A; Ioannidou G; Kritselis G; Liossi P; Giannakouras G; Douzinas EE; Katsilieris I
    Oral Oncol; 2006 Aug; 42(7):675-84. PubMed ID: 16731029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of dose-modified docetaxel plus cisplatin-based induction chemotherapy in Asian patients with locally advanced head and neck cancer.
    Huang CE; Lu CH; Chen PT; Chan CH; Chen WC; Wang WH; Wu JY; Kuan FC; Lee KD; Chen CC
    J Clin Pharm Ther; 2012 Jun; 37(3):342-7. PubMed ID: 21950487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TPF induction chemotherapy and concomitant irradiation with cisplatin and cetuximab in unresectable squamous cell carcinoma of the head and neck.
    Strojan P; Grašič Kuhar C; Žumer B; Kadivec M; Karner K; Fajdiga I; Jančar B; Gale N; Poljak M; Kocjan BJ; Zakotnik B
    Head Neck; 2014 Nov; 36(11):1555-61. PubMed ID: 24123552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cisplatin and 5-fluorouracil in inoperable, stage IV squamous cell carcinoma of the penis.
    Di Lorenzo G; Buonerba C; Federico P; Perdonà S; Aieta M; Rescigno P; D'Aniello C; Puglia L; Petremolo A; Ferro M; Marinelli A; Palmieri G; Sonpavde G; Mirone V; De Placido S
    BJU Int; 2012 Dec; 110(11 Pt B):E661-6. PubMed ID: 22958571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Docetaxel, cisplatin, and fluorouracil combination in neoadjuvant setting in the treatment of locally advanced gastric adenocarcinoma: Phase II NEOTAX study.
    Ozdemir N; Abali H; Vural M; Yalcin S; Oksuzoglu B; Civelek B; Oguz D; Bostanci B; Yalcin B; Zengin N
    Cancer Chemother Pharmacol; 2014 Dec; 74(6):1139-47. PubMed ID: 25234436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer.
    Posner MR; Hershock DM; Blajman CR; Mickiewicz E; Winquist E; Gorbounova V; Tjulandin S; Shin DM; Cullen K; Ervin TJ; Murphy BA; Raez LE; Cohen RB; Spaulding M; Tishler RB; Roth B; Viroglio Rdel C; Venkatesan V; Romanov I; Agarwala S; Harter KW; Dugan M; Cmelak A; Markoe AM; Read PW; Steinbrenner L; Colevas AD; Norris CM; Haddad RI;
    N Engl J Med; 2007 Oct; 357(17):1705-15. PubMed ID: 17960013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Docetaxel/cisplatin followed by FOLFIRI versus the reverse sequence in metastatic gastric cancer.
    Kim JA; Lee J; Han B; Park SH; Park JO; Park YS; Lim HY; Kang WK
    Cancer Chemother Pharmacol; 2011 Jul; 68(1):177-84. PubMed ID: 20878159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.